These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 34762494

  • 1. Exosome-Mediated Transfer of circ-GLIS3 Enhances Temozolomide Resistance in Glioma Cells Through the miR-548m/MED31 Axis.
    Li G, Lan Q.
    Cancer Biother Radiopharm; 2023 Feb; 38(1):62-73. PubMed ID: 34762494
    [Abstract] [Full Text] [Related]

  • 2. Circ_0005198 enhances temozolomide resistance of glioma cells through miR-198/TRIM14 axis.
    Deng Y, Zhu H, Xiao L, Liu C, Meng X.
    Aging (Albany NY); 2020 Dec 09; 13(2):2198-2211. PubMed ID: 33316781
    [Abstract] [Full Text] [Related]

  • 3. Warburg effect-promoted exosomal circ_0072083 releasing up-regulates NANGO expression through multiple pathways and enhances temozolomide resistance in glioma.
    Ding C, Yi X, Chen X, Wu Z, You H, Chen X, Zhang G, Sun Y, Bu X, Wu X, Lin Z, Gu J, Lin Y, Kang D.
    J Exp Clin Cancer Res; 2021 May 11; 40(1):164. PubMed ID: 33975615
    [Abstract] [Full Text] [Related]

  • 4. Exosomal circ-HIPK3 Facilitates Tumor Progression and Temozolomide Resistance by Regulating miR-421/ZIC5 Axis in Glioma.
    Han C, Wang S, Wang H, Zhang J.
    Cancer Biother Radiopharm; 2021 Sep 11; 36(7):537-548. PubMed ID: 32644821
    [Abstract] [Full Text] [Related]

  • 5. Hsa_circ_0110757 upregulates ITGA1 to facilitate temozolomide resistance in glioma by suppressing hsa-miR-1298-5p.
    Li H, Liu Q, Chen Z, Wu M, Zhang C, Su J, Li Y, Zhang C.
    Cell Death Dis; 2021 Mar 05; 12(3):252. PubMed ID: 33674567
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Knockdown of circHIPK3 Facilitates Temozolomide Sensitivity in Glioma by Regulating Cellular Behaviors Through miR-524-5p/KIF2A-Mediated PI3K/AKT Pathway.
    Yin H, Cui X.
    Cancer Biother Radiopharm; 2021 Sep 05; 36(7):556-567. PubMed ID: 32833501
    [Abstract] [Full Text] [Related]

  • 12. Heparanase confers temozolomide resistance by regulation of exosome secretion and circular RNA composition in glioma.
    Si J, Li W, Li X, Cao L, Chen Z, Jiang Z.
    Cancer Sci; 2021 Sep 05; 112(9):3491-3506. PubMed ID: 34036683
    [Abstract] [Full Text] [Related]

  • 13. Circular RNA circ_0079593 indicates a poor prognosis and facilitates cell growth and invasion by sponging miR-182 and miR-433 in glioma.
    Qu Y, Zhu J, Liu J, Qi L.
    J Cell Biochem; 2019 Oct 05; 120(10):18005-18013. PubMed ID: 31148222
    [Abstract] [Full Text] [Related]

  • 14. miR-1297 sensitizes glioma cells to temozolomide (TMZ) treatment through targeting adrenomedullin (ADM).
    He Z, Cheng M, Hu J, Liu L, Liu P, Chen L, Cao D, Tang J.
    J Transl Med; 2022 Oct 01; 20(1):443. PubMed ID: 36183123
    [Abstract] [Full Text] [Related]

  • 15. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
    Tang JH, Yang L, Chen JX, Li QR, Zhu LR, Xu QF, Huang GH, Zhang ZX, Xiang Y, Du L, Zhou Z, Lv SQ.
    Cancer Commun (Lond); 2019 Dec 03; 39(1):81. PubMed ID: 31796105
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.